Floatz logo

Ferumoxytol

Cerebral Atherosclerosis

Northwestern UniversityOtherPhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
89/ 100

Competitive context

11 Active assets in the Cerebral Atherosclerosis cohort.

Asset / SponsorPhaseRating
Rosuvastatin
Samsung Medical Center
Phase 4BB
Recaticimab
Peking Union Medical College Hospital
Phase 4BB
Lipitor
General Hospital of Shenyang Military Region
Phase 4BB
Rucacuzumab
Peking Union Medical College Hospital
Phase 4BB
Probucol
General Hospital of Shenyang Military Region
Phase 4BB

View all 12 →

Same molecule, other indications

Ferumoxytol is also rated in:

glioblastomaDormant
B
Indicative ·
60 / 100
View asset →
multiple sclerosisDormant
B
Indicative ·
58 / 100
View asset →
restless legs syndromeDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →